A role for HSP70 in protecting against indomethacin-induced gastric lesions

Shintaro Suemasu, Ken Ichiro Tanaka, Takushi Namba, Tomoaki Ishihara, Takashi Katsu, Mitsuaki Fujimoto, Hiroaki Adachi, Gen Sobue, Koji Takeuchi, Akira Nakai, Tohru Mizushima

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

A major clinical problem encountered with the use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as indomethacin, is gastrointestinal complications.. Both NSAID-dependent cyclooxygenase inhibition and gastric mucosal apoptosis are involved in NSAID-produced gastric lesions, and this apoptosis is mediated by the endoplasmic reticulum stress response and resulting activation of Bax. Heat shock-proteins (HSPs) have been suggested to protect gastric mucosa from NSAID-induced lesions; here we have tested this idea genetically. The severity of gastric lesions produced by indomethacin was worse in mice lacking heat shock factor 1 (HSF1), a transcription factor for hsp genes, than in control mice. Indomethacin administration up-regulated the expression of gastric mucosal HSP70. Indomethacin-induced gastric lesions were ameliorated in transgenic mice expressing HSP70. After indomethacin administration, fewer apoptotic cells were observed in the gastric mucosa of transgenic mice expressing HSP70 than in wild-type mice, whereas the gastric levels of prostaglandin E2 for the two were indistinguishable. This suggests that expression of HSP70 ameliorates indomethacin-induced gastric lesions by affecting mucosal apoptosis. Suppression of HSP70 expression in vitro stimulated indomethacin-induced apoptosis and activation of Bax but not the endoplasmic reticulitm stress response. Geranylgeranylacetone induced HSP70 at gastric mucosa in an HSFI-dependent manner and suppressed the formation of indomethacin-induced gastric lesions in wild-type mice but not in HSF1-null mice. The results of this study provide direct genetic evidence that expression of HSP70 confers gastric protection against indomethacin-induced lesions by inhibiting the activation of Bax. The HSP inducing activity of geranylgeranylacetone seems to contribute to its gastroprotective activity against indomethacin.

Original languageEnglish
Pages (from-to)19705-19715
Number of pages11
JournalJournal of Biological Chemistry
Volume284
Issue number29
DOIs
Publication statusPublished - 2009 Jul 17
Externally publishedYes

Fingerprint

Indomethacin
Stomach
geranylgeranylacetone
Anti-Inflammatory Agents
Gastric Mucosa
Apoptosis
Chemical activation
Heat-Shock Proteins
Transgenic Mice
Pharmaceutical Preparations
Gastrointestinal Agents
Endoplasmic Reticulum Stress
Prostaglandin-Endoperoxide Synthases
Dinoprostone
Transcription Factors
Genes
Cells

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Suemasu, S., Tanaka, K. I., Namba, T., Ishihara, T., Katsu, T., Fujimoto, M., ... Mizushima, T. (2009). A role for HSP70 in protecting against indomethacin-induced gastric lesions. Journal of Biological Chemistry, 284(29), 19705-19715. https://doi.org/10.1074/jbc.M109.006817

A role for HSP70 in protecting against indomethacin-induced gastric lesions. / Suemasu, Shintaro; Tanaka, Ken Ichiro; Namba, Takushi; Ishihara, Tomoaki; Katsu, Takashi; Fujimoto, Mitsuaki; Adachi, Hiroaki; Sobue, Gen; Takeuchi, Koji; Nakai, Akira; Mizushima, Tohru.

In: Journal of Biological Chemistry, Vol. 284, No. 29, 17.07.2009, p. 19705-19715.

Research output: Contribution to journalArticle

Suemasu, S, Tanaka, KI, Namba, T, Ishihara, T, Katsu, T, Fujimoto, M, Adachi, H, Sobue, G, Takeuchi, K, Nakai, A & Mizushima, T 2009, 'A role for HSP70 in protecting against indomethacin-induced gastric lesions', Journal of Biological Chemistry, vol. 284, no. 29, pp. 19705-19715. https://doi.org/10.1074/jbc.M109.006817
Suemasu S, Tanaka KI, Namba T, Ishihara T, Katsu T, Fujimoto M et al. A role for HSP70 in protecting against indomethacin-induced gastric lesions. Journal of Biological Chemistry. 2009 Jul 17;284(29):19705-19715. https://doi.org/10.1074/jbc.M109.006817
Suemasu, Shintaro ; Tanaka, Ken Ichiro ; Namba, Takushi ; Ishihara, Tomoaki ; Katsu, Takashi ; Fujimoto, Mitsuaki ; Adachi, Hiroaki ; Sobue, Gen ; Takeuchi, Koji ; Nakai, Akira ; Mizushima, Tohru. / A role for HSP70 in protecting against indomethacin-induced gastric lesions. In: Journal of Biological Chemistry. 2009 ; Vol. 284, No. 29. pp. 19705-19715.
@article{4452911f515445a585a5b4702a8e0aae,
title = "A role for HSP70 in protecting against indomethacin-induced gastric lesions",
abstract = "A major clinical problem encountered with the use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as indomethacin, is gastrointestinal complications.. Both NSAID-dependent cyclooxygenase inhibition and gastric mucosal apoptosis are involved in NSAID-produced gastric lesions, and this apoptosis is mediated by the endoplasmic reticulum stress response and resulting activation of Bax. Heat shock-proteins (HSPs) have been suggested to protect gastric mucosa from NSAID-induced lesions; here we have tested this idea genetically. The severity of gastric lesions produced by indomethacin was worse in mice lacking heat shock factor 1 (HSF1), a transcription factor for hsp genes, than in control mice. Indomethacin administration up-regulated the expression of gastric mucosal HSP70. Indomethacin-induced gastric lesions were ameliorated in transgenic mice expressing HSP70. After indomethacin administration, fewer apoptotic cells were observed in the gastric mucosa of transgenic mice expressing HSP70 than in wild-type mice, whereas the gastric levels of prostaglandin E2 for the two were indistinguishable. This suggests that expression of HSP70 ameliorates indomethacin-induced gastric lesions by affecting mucosal apoptosis. Suppression of HSP70 expression in vitro stimulated indomethacin-induced apoptosis and activation of Bax but not the endoplasmic reticulitm stress response. Geranylgeranylacetone induced HSP70 at gastric mucosa in an HSFI-dependent manner and suppressed the formation of indomethacin-induced gastric lesions in wild-type mice but not in HSF1-null mice. The results of this study provide direct genetic evidence that expression of HSP70 confers gastric protection against indomethacin-induced lesions by inhibiting the activation of Bax. The HSP inducing activity of geranylgeranylacetone seems to contribute to its gastroprotective activity against indomethacin.",
author = "Shintaro Suemasu and Tanaka, {Ken Ichiro} and Takushi Namba and Tomoaki Ishihara and Takashi Katsu and Mitsuaki Fujimoto and Hiroaki Adachi and Gen Sobue and Koji Takeuchi and Akira Nakai and Tohru Mizushima",
year = "2009",
month = "7",
day = "17",
doi = "10.1074/jbc.M109.006817",
language = "English",
volume = "284",
pages = "19705--19715",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "29",

}

TY - JOUR

T1 - A role for HSP70 in protecting against indomethacin-induced gastric lesions

AU - Suemasu, Shintaro

AU - Tanaka, Ken Ichiro

AU - Namba, Takushi

AU - Ishihara, Tomoaki

AU - Katsu, Takashi

AU - Fujimoto, Mitsuaki

AU - Adachi, Hiroaki

AU - Sobue, Gen

AU - Takeuchi, Koji

AU - Nakai, Akira

AU - Mizushima, Tohru

PY - 2009/7/17

Y1 - 2009/7/17

N2 - A major clinical problem encountered with the use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as indomethacin, is gastrointestinal complications.. Both NSAID-dependent cyclooxygenase inhibition and gastric mucosal apoptosis are involved in NSAID-produced gastric lesions, and this apoptosis is mediated by the endoplasmic reticulum stress response and resulting activation of Bax. Heat shock-proteins (HSPs) have been suggested to protect gastric mucosa from NSAID-induced lesions; here we have tested this idea genetically. The severity of gastric lesions produced by indomethacin was worse in mice lacking heat shock factor 1 (HSF1), a transcription factor for hsp genes, than in control mice. Indomethacin administration up-regulated the expression of gastric mucosal HSP70. Indomethacin-induced gastric lesions were ameliorated in transgenic mice expressing HSP70. After indomethacin administration, fewer apoptotic cells were observed in the gastric mucosa of transgenic mice expressing HSP70 than in wild-type mice, whereas the gastric levels of prostaglandin E2 for the two were indistinguishable. This suggests that expression of HSP70 ameliorates indomethacin-induced gastric lesions by affecting mucosal apoptosis. Suppression of HSP70 expression in vitro stimulated indomethacin-induced apoptosis and activation of Bax but not the endoplasmic reticulitm stress response. Geranylgeranylacetone induced HSP70 at gastric mucosa in an HSFI-dependent manner and suppressed the formation of indomethacin-induced gastric lesions in wild-type mice but not in HSF1-null mice. The results of this study provide direct genetic evidence that expression of HSP70 confers gastric protection against indomethacin-induced lesions by inhibiting the activation of Bax. The HSP inducing activity of geranylgeranylacetone seems to contribute to its gastroprotective activity against indomethacin.

AB - A major clinical problem encountered with the use of nonsteroidal anti-inflammatory drugs (NSAIDs), such as indomethacin, is gastrointestinal complications.. Both NSAID-dependent cyclooxygenase inhibition and gastric mucosal apoptosis are involved in NSAID-produced gastric lesions, and this apoptosis is mediated by the endoplasmic reticulum stress response and resulting activation of Bax. Heat shock-proteins (HSPs) have been suggested to protect gastric mucosa from NSAID-induced lesions; here we have tested this idea genetically. The severity of gastric lesions produced by indomethacin was worse in mice lacking heat shock factor 1 (HSF1), a transcription factor for hsp genes, than in control mice. Indomethacin administration up-regulated the expression of gastric mucosal HSP70. Indomethacin-induced gastric lesions were ameliorated in transgenic mice expressing HSP70. After indomethacin administration, fewer apoptotic cells were observed in the gastric mucosa of transgenic mice expressing HSP70 than in wild-type mice, whereas the gastric levels of prostaglandin E2 for the two were indistinguishable. This suggests that expression of HSP70 ameliorates indomethacin-induced gastric lesions by affecting mucosal apoptosis. Suppression of HSP70 expression in vitro stimulated indomethacin-induced apoptosis and activation of Bax but not the endoplasmic reticulitm stress response. Geranylgeranylacetone induced HSP70 at gastric mucosa in an HSFI-dependent manner and suppressed the formation of indomethacin-induced gastric lesions in wild-type mice but not in HSF1-null mice. The results of this study provide direct genetic evidence that expression of HSP70 confers gastric protection against indomethacin-induced lesions by inhibiting the activation of Bax. The HSP inducing activity of geranylgeranylacetone seems to contribute to its gastroprotective activity against indomethacin.

UR - http://www.scopus.com/inward/record.url?scp=67651063544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651063544&partnerID=8YFLogxK

U2 - 10.1074/jbc.M109.006817

DO - 10.1074/jbc.M109.006817

M3 - Article

C2 - 19439408

AN - SCOPUS:67651063544

VL - 284

SP - 19705

EP - 19715

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 29

ER -